Biosynex Overview
- Founded
-
2005
- Status
-
Public
- Employees
-
272
- Stock Symbol
-
ALBIO
- Investments
-
20
- Share Price
-
$10.03
- (As of Friday Closing)
Biosynex General Information
Description
Biosynex SA is engaged in the research, development, and manufacturing of fast diagnosis tests on membrane support for health professionals. It manufactures and markets medical devices for screening, diagnosis.
Contact Information
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Other Healthcare Services
Stock Exchange
PAR
Primary Office
- 22 Boulevard Sébastien Brant
- Graffenstaden
- 67400 Illkirch
- France
+33 03 00 00 00 00
Biosynex Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $10.03 | $9.94 | $7.49 - $20.71 | $103M | 10.3M | 13.6K | $1.61 |
Biosynex Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2022 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 104,801 | 104,801 | 292,347 | 188,267 |
| Revenue | 206,692 | 206,692 | 452,268 | 175,427 |
| EBITDA | 42,125 | 42,125 | 173,233 | 59,094 |
| Net Income | 16,462 | 16,462 | 122,964 | 35,759 |
| Total Assets | 279,189 | 279,189 | 304,505 | 155,067 |
| Total Debt | 55,847 | 55,847 | 39,980 | 19,396 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Biosynex Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biosynex Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Biosynex SA is engaged in the research, development, and manufacturing of fast diagnosis tests on membrane support for h
Diagnostic Equipment
Illkirch, France
272
As of 2022
00.000
00000000000
00.000
000000
ore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, su
0000000000 00000000
Cambridge, United Kingdom
00
As of 0000
000.00
00.00
0000-00-00
000000&0
000.00
000000
commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit ess
0000000000 000000000
San Diego, CA
00
As of 0000
000.00
0000000000 0
000.00
Add Comparison
Biosynex Competitors (4)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cambridge Clinical Laboratories | Formerly VC-backed | Cambridge, United Kingdom | 00 | 000.00 | 000000&0 | 000.00 |
| 000000000 | Venture Capital-Backed | San Diego, CA | 00 | 000.00 | 0000000000 0 | 000.00 |
| 00000 00000000000 | Corporation | Secaucus, NJ | 00000 | 000000 - 000 | ||
| 00000000 | Venture Capital-Backed | San Diego, CA | 00 | 00000 | 00000000000 | 00000 |
Biosynex Patents
Biosynex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-212808-S | Thermometer [including medical thermometer] with its charging holder | Active | 25-Oct-2021 | ||
| AU-2017224875-B2 | Method for detecting imminent childbirth | Active | 26-Feb-2016 | 00000000000 | 0 |
| AU-2017224875-A1 | Method for detecting imminent childbirth | Active | 26-Feb-2016 | 00000000000 | |
| CA-3015438-A1 | Method for detecting imminent childbirth | Pending | 26-Feb-2016 | 00000000000 | |
| EP-3420360-A1 | Method for detecting imminent childbirth | Active | 26-Feb-2016 | G01N33/6869 |
Biosynex Executive Team (4)
Biosynex Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 0000000 | Biosynex | Chief Executive Officer & Chairman | 000 0000 |
| 0000000 00000 | Biosynex | Board Member & Executive | 000 0000 |
Biosynex Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Biosynex Investments & Acquisitions (20)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000 | 27-Apr-2023 | 0000000000 | 000.00 | Diagnostic Equipment | 00000 000 |
| 000000000000 | 23-Mar-2023 | 0000000000 | |||
| 0000000000 | 20-Dec-2022 | 0000000000 | Laboratory Services (Healthcare) | 00000 000 | |
| 00000 | 07-Oct-2022 | 0000000000 | Diagnostic Equipment | ||
| Bigix Pharma | 06-Oct-2022 | Merger/Acquisition | Distributors/Wholesale |
Biosynex Subsidiaries (8)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Doc2U | Diagnostic Equipment | Toulouse, France | 2020 |
| 0000000000 | Laboratory Services (Healthcare) | Charlottenlund, Denmark | 0000 |
| 0000000 | Other Commercial Products | Evry, France | 0000 |
| 000000 | Diagnostic Equipment | Grenoble, France | 0000 |
| 000000000 | Other Devices and Supplies | Romainville, France | 0000 |
Biosynex ESG
Risk Overview
Risk Rating
Updated December, 20, 2022
34.91 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,233
Rank
00.00
Percentile
Healthcare
Industry
00 of 586
Rank
00.00
Percentile
Medical Devices
Subindustry
00 of 200
Rank
00.00
Percentile
